Found 5 matching trials
Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease
PHASE4Study to assess the safety, tolerability and effectiveness of a switching f...
Location
Multiple Locations
Survey on PD Patients With Depressive Symptoms
N/AThe primary objective of this investigation is to conduct a 12-week prospec...
Location
Boehringer Ingelheim Investigational Site
Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome
PHASE2The objective of this trial is to investigate the efficacy and safety of pr...
Location
Boehringer Ingelheim Investigational Site
Special Survey on PD Patients With Renal Dysfunction
N/AThe survey is conducted to collect safety and effectiveness information tar...
Location
Boehringer Ingelheim Investigational Site
Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome
N/AThe survey is conducted to investigate the safety and efficacy of long-term...
Location
Boehringer Ingelheim Investigational Site 119